Independent Behavior of Commensal Flora for Carriage of Fluoroquinolone-Resistant Bacteria in Patients at Admission

被引:23
作者
de Lastours, Victoire [1 ,2 ,3 ]
Chau, Francoise [2 ,3 ]
Tubach, Florence [4 ]
Pasquet, Blandine [4 ]
Ruppe, Etienne [2 ,3 ]
Fantin, Bruno [1 ,2 ,3 ]
机构
[1] Hop Beaujon, AP HP, Dept Internal Med, F-92100 Clichy, France
[2] Paris Diderot Univ, Lab EA3964, Paris, France
[3] Paris Diderot Univ, Sch Med, Paris, France
[4] Hop Xavier Bichat, AP HP, Dept Epidemiol Stat & Clin Res, Paris, France
关键词
ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; KLEBSIELLA-PNEUMONIAE; QUINOLONE RESISTANCE; EMERGENCE; CIPROFLOXACIN; ENTEROBACTERIACEAE; SUSCEPTIBILITY;
D O I
10.1128/AAC.00823-10
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学];
摘要
The important role of commensal flora as a natural reservoir of bacterial resistance is now well established. However, whether the behavior of each commensal flora is similar to that of other floras in terms of rates of carriage and risk factors for bacterial resistance is unknown. During a 6-month period, we prospectively investigated colonization with fluoroquinolone-resistant bacteria in the three main commensal floras from hospitalized patients at admission, targeting Escherichia coli in the fecal flora, coagulase-negative Staphylococcus (CNS) in the nasal flora, and alpha-hemolytic streptococci in the pharyngeal flora. Resistant strains were detected on quinolone-containing selective agar. Clinical and epidemiological data were collected. A total of 555 patients were included. Carriage rates of resistance were 8.0% in E. coli, 30.3% in CNS for ciprofloxacin, and 27.2% in streptococci for levofloxacin; 56% of the patients carried resistance in at least one flora but only 0.9% simultaneously in all floras, which is no more than random. Risk factors associated with the carriage of fluoroquinolone-resistant strains differed between fecal E. coli (i.e., colonization by multidrug-resistant bacteria) and nasal CNS (i.e., age, coming from a health care facility, and previous antibiotic treatment with a fluoroquinolone) while no risk factors were identified for pharyngeal streptococci. Despite high rates of colonization with fluoroquinolone-resistant bacteria, each commensal flora behaved independently since simultaneous carriage of resistance in the three distinct floras was uncommon, and risk factors differed. Consequences of environmental selective pressures vary in each commensal flora according to its local specificities (clinical trial NCT00520715 [http://clinicaltrials.gov/ct2/show/NCT00520715]).
引用
收藏
页码:5193 / 5200
页数:8
相关论文
共 43 条
[1]
Commensals upon us [J].
Alekshun, MN ;
Levy, SB .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (07) :893-900
[2]
Andremont A, 2003, ASM NEWS, V69, P601
[3]
Development of quinolone-resistant strains of Escherichia coli in stools of patients with cirrhosis undergoing norfloxacin prophylaxis:: clinical consequences [J].
Aparicio, JR ;
Such, J ;
Pascual, S ;
Arroyo, A ;
Plazas, J ;
Girona, E ;
Gutiérrez, A ;
de Vera, F ;
Palazón, JM ;
Carnicer, F ;
Pérez-Mateo, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (02) :277-283
[4]
Antimicrobial resistance in commensal flora of pig farmers [J].
Aubry-Damon, H ;
Grenet, K ;
Sall-Ndiaye, P ;
Che, D ;
Cordeiro, E ;
Bougnoux, ME ;
Rigaud, E ;
Le Strat, Y ;
Lemanissier, V ;
Armand-Lefèvre, L ;
Delzescaux, D ;
Desenclos, JC ;
Liénard, M ;
Andremont, A .
EMERGING INFECTIOUS DISEASES, 2004, 10 (05) :873-879
[5]
Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae [J].
Balsalobre, L ;
Ferrándiz, MJ ;
Liñares, J ;
Tubau, F ;
de la Carnpa, AG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2072-2081
[6]
The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported [J].
Bolon, MK ;
Wright, SB ;
Gold, HS ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :1934-1940
[7]
EMERGENCE OF QUINOLONE-RESISTANT ESCHERICHIA-COLI BACTEREMIA IN NEUTROPENIC PATIENTS WITH CANCER WHO HAVE RECEIVED PROPHYLACTIC NORFLOXACIN [J].
CARRATALA, J ;
FERNANDEZSEVILLA, A ;
TUBAU, F ;
CALLIS, M ;
GUDIOL, F .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :557-560
[8]
Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada [J].
Chen, DK ;
McGeer, A ;
de Azavedo, JC ;
Low, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :233-239
[9]
Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments [J].
Crémieux, AC ;
Muller-Serieys, C ;
Panhard, X ;
Delatour, F ;
Tchimichkian, M ;
Mentre, F ;
Andremont, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) :2030-2035
[10]
LEVELS OF RIFAMPIN AND CIPROFLOXACIN IN NASAL SECRETIONS - CORRELATION WITH MIC90 AND ERADICATION OF NASOPHARYNGEAL CARRIAGE OF BACTERIA [J].
DAROUICHE, R ;
PERKINS, B ;
MUSHER, D ;
HAMILL, R ;
TSAI, S .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1124-1127